Teva Pharmaceutical Industries Ltd (TEVA)
13.11
-0.07
(-0.53%)
USD |
NYSE |
Apr 18, 11:31
Teva Pharmaceutical Industries Market Cap: 14.70B for April 18, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 17, 2024 | 14.78B |
| April 16, 2024 | 14.68B |
| April 15, 2024 | 14.83B |
| April 12, 2024 | 14.91B |
| April 11, 2024 | 15.55B |
| April 10, 2024 | 15.53B |
| April 09, 2024 | 15.66B |
| April 08, 2024 | 15.92B |
| April 05, 2024 | 15.98B |
| April 04, 2024 | 15.62B |
| April 03, 2024 | 15.83B |
| April 02, 2024 | 15.54B |
| April 01, 2024 | 15.59B |
| March 28, 2024 | 15.82B |
| March 27, 2024 | 16.18B |
| March 26, 2024 | 15.85B |
| March 25, 2024 | 15.76B |
| March 22, 2024 | 15.57B |
| March 21, 2024 | 15.42B |
| March 20, 2024 | 15.11B |
| March 19, 2024 | 14.97B |
| March 18, 2024 | 14.93B |
| March 15, 2024 | 15.06B |
| March 14, 2024 | 15.13B |
| March 13, 2024 | 15.30B |
| Date | Value |
|---|---|
| March 12, 2024 | 15.12B |
| March 11, 2024 | 14.97B |
| March 08, 2024 | 15.27B |
| March 07, 2024 | 15.37B |
| March 06, 2024 | 15.17B |
| March 05, 2024 | 15.18B |
| March 04, 2024 | 15.07B |
| March 01, 2024 | 15.13B |
| February 29, 2024 | 14.74B |
| February 28, 2024 | 14.68B |
| February 27, 2024 | 14.91B |
| February 26, 2024 | 14.90B |
| February 23, 2024 | 14.45B |
| February 22, 2024 | 14.63B |
| February 21, 2024 | 14.57B |
| February 20, 2024 | 14.65B |
| February 16, 2024 | 14.60B |
| February 15, 2024 | 14.80B |
| February 14, 2024 | 14.76B |
| February 13, 2024 | 14.48B |
| February 12, 2024 | 14.47B |
| February 09, 2024 | 13.46B |
| February 08, 2024 | 13.55B |
| February 07, 2024 | 13.61B |
| February 06, 2024 | 13.73B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
6.726B
Minimum
Aug 15 2019
17.04B
Maximum
Apr 29 2019
10.73B
Average
10.44B
Median
Dec 11 2019
Market Cap Benchmarks
| Viatris Inc | 13.28B |
| Johnson & Johnson | 348.69B |
| GSK PLC | 80.43B |
| Novartis AG | 189.56B |
| Sanofi SA | 113.44B |
Market Cap Related Metrics
| PS Ratio | 0.9284 |
| Price to Book Value | 1.958 |
| Price to Free Cash Flow | 17.47 |
| Price | 13.11 |
| Earnings Yield | -3.59% |
| Operating PE Ratio | 4.609 |
| Normalized PE Ratio | 8.119 |